335 related articles for article (PubMed ID: 20525876)
21. High-dose Humanin analogue applied during ischemia exerts cardioprotection against ischemia/reperfusion injury by reducing mitochondrial dysfunction.
Thummasorn S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28726291
[TBL] [Abstract][Full Text] [Related]
22. Propofol post-conditioning protects against cardiomyocyte apoptosis in hypoxia/reoxygenation injury by suppressing nuclear factor-kappa B translocation via extracellular signal-regulated kinase mitogen-activated protein kinase pathway.
Li H; Tan J; Zou Z; Huang CG; Shi XY
Eur J Anaesthesiol; 2011 Jul; 28(7):525-34. PubMed ID: 21666544
[TBL] [Abstract][Full Text] [Related]
23. Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium.
Hamid SA; Bower HS; Baxter GF
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2598-606. PubMed ID: 17220176
[TBL] [Abstract][Full Text] [Related]
24. Obestatin Plays Beneficial Role in Cardiomyocyte Injury Induced by Ischemia-Reperfusion In Vivo and In Vitro.
Zhang Q; Dong XW; Xia JY; Xu KY; Xu ZR
Med Sci Monit; 2017 May; 23():2127-2136. PubMed ID: 28472020
[TBL] [Abstract][Full Text] [Related]
25. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL
Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017
[TBL] [Abstract][Full Text] [Related]
26. Histamine H2 receptor activation exacerbates myocardial ischemia/reperfusion injury by disturbing mitochondrial and endothelial function.
Luo T; Chen B; Zhao Z; He N; Zeng Z; Wu B; Fukushima Y; Dai M; Huang Q; Xu D; Bin J; Kitakaze M; Liao Y
Basic Res Cardiol; 2013 May; 108(3):342. PubMed ID: 23467745
[TBL] [Abstract][Full Text] [Related]
27. α-Lipoic acid reduces infarct size and preserves cardiac function in rat myocardial ischemia/reperfusion injury through activation of PI3K/Akt/Nrf2 pathway.
Deng C; Sun Z; Tong G; Yi W; Ma L; Zhao B; Cheng L; Zhang J; Cao F; Yi D
PLoS One; 2013; 8(3):e58371. PubMed ID: 23505496
[TBL] [Abstract][Full Text] [Related]
28. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway.
Zhang J; Huang L; Shi X; Yang L; Hua F; Ma J; Zhu W; Liu X; Xuan R; Shen Y; Liu J; Lai X; Yu P
Aging (Albany NY); 2020 Nov; 12(23):24270-24287. PubMed ID: 33232283
[TBL] [Abstract][Full Text] [Related]
29. Influences of remifentanil on myocardial ischemia-reperfusion injury and the expressions of Bax and Bcl-2 in rats.
Li J; Hu HP; Li Y; Shao W; Zhang JZ; Wang LM
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8951-8960. PubMed ID: 30575939
[TBL] [Abstract][Full Text] [Related]
30. Cardio-Protective Effects of Germinated Brown Rice Extract Against Myocardial Ischemia Reperfusion Injury.
Petchdee S; Laosripaiboon W; Jarussophon N; Kumphune S
High Blood Press Cardiovasc Prev; 2020 Jun; 27(3):251-258. PubMed ID: 32266706
[TBL] [Abstract][Full Text] [Related]
31. Induction of cardioprotection by small netrin-1-derived peptides.
Li Q; Cai H
Am J Physiol Cell Physiol; 2015 Jul; 309(2):C100-6. PubMed ID: 25924621
[TBL] [Abstract][Full Text] [Related]
32. Remifentanil Induces Cardio Protection Against Ischemia/Reperfusion Injury by Inhibiting Endoplasmic Reticulum Stress Through the Maintenance of Zinc Homeostasis.
Sheng M; Zhang G; Wang J; Yang Q; Zhao H; Cheng X; Xu Z
Anesth Analg; 2018 Jul; 127(1):267-276. PubMed ID: 29771714
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of Hydrogen Sulfide Preconditioning-Associated Protection Against Ischemia-Reperfusion Injury Differs in Diabetic Heart That Develops Myopathy.
Ansari M; Kurian GA
Cardiovasc Toxicol; 2020 Apr; 20(2):155-167. PubMed ID: 31317389
[TBL] [Abstract][Full Text] [Related]
34. The effects of curcumin post-treatment against myocardial ischemia and reperfusion by activation of the JAK2/STAT3 signaling pathway.
Duan W; Yang Y; Yan J; Yu S; Liu J; Zhou J; Zhang J; Jin Z; Yi D
Basic Res Cardiol; 2012 May; 107(3):263. PubMed ID: 22466958
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of Mas G-protein signaling improves coronary blood flow, reduces myocardial infarct size, and provides long-term cardioprotection.
Zhang T; Li Z; Dang H; Chen R; Liaw C; Tran TA; Boatman PD; Connolly DT; Adams JW
Am J Physiol Heart Circ Physiol; 2012 Jan; 302(1):H299-311. PubMed ID: 22003054
[TBL] [Abstract][Full Text] [Related]
36. SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.
Strande JL; Hsu A; Su J; Fu X; Gross GJ; Baker JE
Basic Res Cardiol; 2007 Jul; 102(4):350-8. PubMed ID: 17468933
[TBL] [Abstract][Full Text] [Related]
37. Cardioprotective effect of breviscapine: inhibition of apoptosis in H9c2 cardiomyocytes via the PI3K/Akt/eNOS pathway following simulated ischemia/reperfusion injury.
Wang J; Ji SY; Liu SZ; Jing R; Lou WJ
Pharmazie; 2015 Sep; 70(9):593-7. PubMed ID: 26492644
[TBL] [Abstract][Full Text] [Related]
38. Functional cardiac orexin receptors: role of orexin-B/orexin 2 receptor in myocardial protection.
Patel VH; Karteris E; Chen J; Kyrou I; Mattu HS; Dimitriadis GK; Rodrigo G; Antoniades C; Antonopoulos A; Tan BK; Hillhouse EW; Ng A; Randeva HS
Clin Sci (Lond); 2018 Dec; 132(24):2547-2564. PubMed ID: 30467191
[TBL] [Abstract][Full Text] [Related]
39. Parstatin: a cryptic peptide involved in cardioprotection after ischaemia and reperfusion injury.
Strande JL; Widlansky ME; Tsopanoglou NE; Su J; Wang J; Hsu A; Routhu KV; Baker JE
Cardiovasc Res; 2009 Jul; 83(2):325-34. PubMed ID: 19380418
[TBL] [Abstract][Full Text] [Related]
40. L-Carnitine Attenuates Cardiac Dysfunction by Ischemic Insults Through Akt Signaling Pathway.
Xue M; Chen X; Guo Z; Liu X; Bi Y; Yin J; Hu H; Zhu P; Zhuang J; Cates C; Rousselle T; Li J
Toxicol Sci; 2017 Dec; 160(2):341-350. PubMed ID: 28973678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
